Creo Medical Group 

$0.2256
53
+$0.03+12.8% Tuesday 20:00

Statistics

Day High
0.2
Day Low
0.2
52W High
0.2256
52W Low
0.185
Volume
2,500
Avg. Volume
357
Mkt Cap
93.05M
P/E Ratio
-
Dividend Yield
-
Dividend
-

Upcoming

Earnings

30SepExpected
Q1 2024
Q2 2024
Q1 2025
Q2 2025
Q1 2026
Next
-0.04
-0.03
-0.01
0
Expected EPS
N/A
Actual EPS
N/A

Financials

63.94%Profit Margin
Profitable
2020
2021
2022
2023
2024
2025
11.9MRevenue
7.61MNet Income

People Also Follow

This list is based on the watchlists of people on Stock Events who follow CMEOF. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Boston Scientific
BSX
Mkt Cap75.11B
Boston Scientific Corporation offers medical solutions that compete directly with Creo Medical's advanced energy devices, particularly in the field of minimally invasive surgeries.
Medtronic
MDT
Mkt Cap116.83B
Medtronic plc provides a wide range of medical technologies, including surgical devices that rival Creo Medical's offerings in energy-based surgical and therapeutic solutions.
Johnson & Johnson
JNJ
Mkt Cap627.42B
Johnson & Johnson, through its medical devices segment, competes in the same space as Creo Medical by offering a variety of surgical instruments and medical equipment.
Intuitive Surgical
ISRG
Mkt Cap139.37B
Intuitive Surgical, Inc. specializes in robotic-assisted surgery, competing with Creo Medical's focus on minimally invasive surgical technologies.
Smith & Nephew
SNN
Mkt Cap12.48B
Smith & Nephew plc manufactures medical equipment for surgery, which competes with Creo Medical's surgical devices, especially in the areas of wound management and endoscopy.
Stryker
SYK
Mkt Cap130.11B
Stryker Corporation is a direct competitor in the medical technology field, offering surgical equipment and medical devices that challenge Creo Medical's product range.
Zimmer Biomet
ZBH
Mkt Cap19.2B
Zimmer Biomet Holdings, Inc. competes with Creo Medical in the development and marketing of surgical solutions and orthopedic devices.
Baxter International
BAX
Mkt Cap13.82B
Baxter International Inc. provides a broad range of medical devices that compete with Creo Medical's offerings, particularly in the areas of critical care and surgery.
Abbott Laboratories
ABT
Mkt Cap192.51B
Abbott Laboratories offers medical devices and healthcare solutions that compete across several of Creo Medical's key areas, including vascular therapy and minimally invasive surgeries.
Edwards Lifesciences
EW
Mkt Cap52.8B
Edwards Lifesciences Corporation is a competitor in the field of medical technology, focusing on products for surgical and critical care, which overlaps with Creo Medical's market.

About

Creo Medical Limited, a UK-based enterprise and subsidiary of Creo Medical Group plc, specializes in the innovation and creation of electrosurgical medical devices for surgical endoscopy applications. Founded in 2003 as MicroOncology Ltd and headquartered in Chepstow, the company's core offering is Croma, an advanced energy platform. This platform is engineered to power a diverse collection of multi-modal instruments, thereby enhancing therapeutic interventions for both medical professionals and patients. Its extensive product portfolio includes specialized tools such as Speedboat Inject, an adaptable energy instrument designed for flexible endoscopic procedures; Speedboat Slim, a flexible bipolar radiofrequency (RF) and microwave device for precise tissue cutting and coagulation; MicroBlate Fine, a microwave needle for ablation; MicroBlate Flex, a flexible microwave ablation device; SlypSeal Flex, a flexible haemostasis device engineered to control upper and lower gastrointestinal bleeds; and SpydrBlade Flex, a flexible scissor-like instrument that integrates bipolar RF and microwave technology to grasp, cut, and coagulate highly vascularized tissues.
Show more...
CEO
Mr. Craig Jonathan Gulliford
Employees
104
Country
United Kingdom
ISIN
GB00BZ1BLL44
WKN
000A2DH40

Listings

0 Comments

Share your thoughts

FAQ

What is Creo Medical Group stock price today?
The current price of CMEOF is $0.23 USD — it has increased by +12.8% in the past 24 hours. Watch Creo Medical Group stock price performance more closely on the chart.
What is Creo Medical Group stock ticker?
Depending on the exchange, the stock ticker may vary. For instance, on OTC Link exchange Creo Medical Group stocks are traded under the ticker CMEOF.
What is Creo Medical Group market cap?
Today Creo Medical Group has the market capitalization of 93.05M
When is the next Creo Medical Group earnings date?
Creo Medical Group is going to release the next earnings report on September 30, 2026.
What is Creo Medical Group revenue for the last year?
Creo Medical Group revenue for the last year amounts to 11.9M USD.
What is Creo Medical Group net income for the last year?
CMEOF net income for the last year is 7.61M USD.
How many employees does Creo Medical Group have?
As of August 23, 2026, the company has 104 employees.
In which sector is Creo Medical Group located?
Creo Medical Group operates in the Other sector.
When did Creo Medical Group complete a stock split?
Creo Medical Group has not had any recent stock splits.
Where is Creo Medical Group headquartered?
Creo Medical Group is headquartered in Chepstow, United Kingdom.